Melanie Leydin
Director of Finance/CFO bei INVION LIMITED
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mathew Watkins | M | - | 6 Jahre | |
| Peter Hugh Lloyd | M | - | 39 Jahre | |
| Laura McBain | F | - | 7 Jahre | |
| Stefan Ross | M | - | 6 Jahre | |
| Shane Tanner | M | 70 | 19 Jahre | |
| Sam Riggall | M | 51 | 11 Jahre | |
| Justin Walter | M | - | 8 Jahre | |
| Richard H. Irving | M | - | - | |
| Paul Salter | M | - | 11 Jahre | |
| Ted Dhanik | M | - | 7 Jahre | |
| Benjamin Stockdale | M | - | 11 Jahre | |
| Rebecca Wilson | F | - | 7 Jahre | |
| Simon Eley | M | 50 | 6 Jahre | |
| Roksan Libinaki | M | - | 23 Jahre | |
| Gregory Collier | M | - | 9 Jahre | |
| Matthew Driscoll | M | 60 | 16 Jahre | |
| Shaun Verner | M | - | 8 Jahre | |
| Kurtis Rintala | M | 53 | 7 Jahre | |
| John Sood | M | - | 16 Jahre | |
| Brendan Boyd | M | - | 16 Jahre | |
| Brendan Jesser | M | - | 10 Jahre | |
| Pauline Gately | F | 62 | 5 Jahre | |
| Stephen Moulton | M | - | 7 Jahre | |
| Julie Phillips | F | - |
BioDiem Ltd.
 BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | 15 Jahre |
| Steven Yatomi-Clarke | M | - | 10 Jahre | |
| Michael Andrews | M | - | - | |
| John Walstab | M | - | 2 Jahre | |
| Mark Lochtenberg | M | - | - | |
| William Souter | M | - | - | |
| Robert Antulov | M | 60 | 6 Jahre | |
| Julian Challingsworth | M | - | 2 Jahre | |
| Kate Quirke | F | - | 6 Jahre | |
| Richard John Loveridge | M | - | 7 Jahre | |
| Brendon Lau | M | - | - | |
| Louise Thurgood | F | - | 3 Jahre | |
| Kevin Shaw | M | - | 3 Jahre | |
| David Detata | M | - | 7 Jahre | |
| Richard Morrow | M | - | 3 Jahre | |
| Anna Nahajski-Staples | F | - | 4 Jahre | |
| Todd Williams | M | - | 6 Jahre | |
| Kaye Hocking | F | - | - | |
| Susie Henderson | F | - | - | |
| Naomi Lawrie | F | - | 1 Jahre | |
| Kevin MacNeill | M | - | 5 Jahre | |
| Victoria Weekes | F | - | 3 Jahre | |
| Stefanie Loader | F | - | 7 Jahre | |
| Oliver Kleinhempel | M | 42 | 5 Jahre | |
| Thomas Young | M | - | 2 Jahre | |
| Greg Keane | M | - | 7 Jahre | |
| Thian Chew | M | - | 7 Jahre | |
| Stuart Rechner | M | 44 | 10 Jahre | |
| Robert Tindall | M | - | 7 Jahre | |
| Richard John Malcolm | M | 71 | 6 Jahre | |
| Stephen Layton | M | - | 7 Jahre | |
| Ian Zacharia Tchacos | M | - | 8 Jahre | |
| William D. A. Bridge | M | - | 1 Jahre | |
| Jim Askew | M | 74 | 10 Jahre | |
| Ross Murdoch | M | - | 9 Jahre | |
| Peter Mullens | M | 63 | 3 Jahre | |
| Simon O'Loughlin | M | 66 | 5 Jahre | |
| Alastair McGregor | M | - | 6 Jahre | |
| Leo de Maria | M | - | 10 Jahre | |
| Peter Hood | M | - | 6 Jahre | |
| Geoffrey Sam | M | - | 8 Jahre | |
| Simon Taylor | M | - | 5 Jahre | |
| Sara Watts | F | - | 5 Jahre | |
| Peter Doyle | M | - | 7 Jahre | |
| Eric Finlayson | M | 63 | 9 Jahre | |
| Jose Caldeira | M | - | 10 Jahre | |
| David Dearie | M | - | 5 Jahre | |
| David Clark | M | - | 10 Jahre | |
| John Beevers | M | - | 4 Jahre | |
| Andrew Demetriou | M | 63 | 10 Jahre | |
| Terry Sinclair | M | - | 4 Jahre | |
| Daniel Sharp | M | - | 3 Jahre | |
| Paul Donnelly | M | - | 6 Jahre | |
| Lisa Bahash | F | - | 6 Jahre | |
| Domenic Panaccio | M | - | 2 Jahre | |
| Ellen Feigal | M | 69 | 1 Jahre | |
| Claire Newstead-Sinclair | F | - | 3 Jahre | |
| Damien Hannes | M | 68 |
BioDiem Ltd.
BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia. | 2 Jahre |
| Cheryl Hayman | F | - | 1 Jahre | |
| Paul David Gavin | M | - | 22 Jahre | |
| Andrew Melville Knox | M | - | 4 Jahre | |
| Josephine Lorenz | F | - | 1 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Justin Mouchacca | M | - |
Leydin Freyer Corporate Pty Ltd.
 Leydin Freyer Corporate Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Vistra Group Ltd., Leydin Freyer Corporate Pty Ltd. is an Australian company that provides accounting services. The private company is based in South Melbourne, Australia. The company was founded by Melanie Jaye Leydin. Leydin Freyer Corporate was acquired by Vistra Ltd. on November 01, 2021. | 8 Jahre |
| Kevin W. Nichol | M | - | 5 Jahre | |
| Mark Simari | M | 54 | 15 Jahre | |
| Ranko Matic | M | 56 | 7 Jahre | |
| Garrick Ralph Higgins | M | 68 | 10 Jahre | |
| Danie van den Bergh | M | - | 3 Jahre | |
| Peter James Avery | M | 62 | 4 Jahre | |
| Ernest Eadie | M | 70 | 15 Jahre | |
| Gregory Toll | M | 71 | 12 Jahre | |
| Guy Ralph Burnett | M | 55 | 4 Jahre | |
| Andrew Harrison | M | - | 15 Jahre | |
| David Leavy | M | - | 4 Jahre | |
| Tolga Kumova | M | 46 | 7 Jahre | |
| Jennifer Currie | F | - | 4 Jahre | |
| Timothy Markwell | M | - | 6 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Australien | 92 | 92,00% |
| Vereinigte Staaten | 4 | 4,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Melanie Leydin
- Persönliches Netzwerk
